MOLECULAR BASIS OF FATTY LIVER INHIBITION BY SODIUM BORATES
sodium borates are provided and alone as an active ingredient to prevent and/or treat fatty liver. In addition, the sodium borates reduce the expression levels of AADIPOR2, PRKAG2, IRS1, PIK3R1, NFKB1, MAP3K11, BID, CYCS, BAX, CASP3 and TGFB1 genes in the non-alcoholic fatty liver pathway and thereb...
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
31.07.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | sodium borates are provided and alone as an active ingredient to prevent and/or treat fatty liver. In addition, the sodium borates reduce the expression levels of AADIPOR2, PRKAG2, IRS1, PIK3R1, NFKB1, MAP3K11, BID, CYCS, BAX, CASP3 and TGFB1 genes in the non-alcoholic fatty liver pathway and thereby to prevent and/or treat fatty liver by inhibiting the functioning of the non-alcoholic fatty liver pathway. |
|---|---|
| AbstractList | sodium borates are provided and alone as an active ingredient to prevent and/or treat fatty liver. In addition, the sodium borates reduce the expression levels of AADIPOR2, PRKAG2, IRS1, PIK3R1, NFKB1, MAP3K11, BID, CYCS, BAX, CASP3 and TGFB1 genes in the non-alcoholic fatty liver pathway and thereby to prevent and/or treat fatty liver by inhibiting the functioning of the non-alcoholic fatty liver pathway. |
| Author | CEBECI, Emre ABDIK, Hüseyin SAHIN, Fikrettin |
| Author_xml | – fullname: CEBECI, Emre – fullname: SAHIN, Fikrettin – fullname: ABDIK, Hüseyin |
| BookMark | eNrjYmDJy89L5WSw9vX3cXUO9XEMUnByDPYMVvB3U3BzDAmJVPDxDHMNUvD08_B08gzx9PdTcIpUCPZ38Qz1VXDyD3IMcQ3mYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgEmRqaGhubGjibGRCgBAI8cKpo |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | MOLEKULARE BASIS VON FETTLEBERHEMMUNG DURCH NATRIUMBORATE BASE MOLÉCULAIRE D'INHIBITION DE LA STÉATOSE HÉPATIQUE PAR DES BORATES DE SODIUM |
| ExternalDocumentID | EP4251173A4 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP4251173A43 |
| IEDL.DBID | EVB |
| IngestDate | Fri Aug 09 05:00:33 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP4251173A43 |
| Notes | Application Number: EP20200963791 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240731&DB=EPODOC&CC=EP&NR=4251173A4 |
| ParticipantIDs | epo_espacenet_EP4251173A4 |
| PublicationCentury | 2000 |
| PublicationDate | 20240731 |
| PublicationDateYYYYMMDD | 2024-07-31 |
| PublicationDate_xml | – month: 07 year: 2024 text: 20240731 day: 31 |
| PublicationDecade | 2020 |
| PublicationYear | 2024 |
| RelatedCompanies | Yeditepe Universitesi |
| RelatedCompanies_xml | – name: Yeditepe Universitesi |
| Score | 3.5568995 |
| Snippet | sodium borates are provided and alone as an active ingredient to prevent and/or treat fatty liver. In addition, the sodium borates reduce the expression levels... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | MOLECULAR BASIS OF FATTY LIVER INHIBITION BY SODIUM BORATES |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240731&DB=EPODOC&locale=&CC=EP&NR=4251173A4 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5qFfWmVbG-2IPkFnxk01QkSB4bGsmLJi3tqWTjBnpJi434952NbfWil2XYhWF34JvX7swC3PZ7T5zjoOpvPFepliOkhFGowhBarud9WpTyRjeMeoMRfZ3okxbMN7UwTZ_Qz6Y5IiKqQLzXjb5e_iSx3OZt5eqOz3Fq8eJlpquso2MZnqBScW2TJbEbO4rjIKVEQ5NKV9rQLLoDu-hFGxIMbGzLopTlb4viHcFegsyq-hhaourAgbP5eK0D--H6vhvJNfRWJ_AcxgFzRoE1JLaV-imJPeJZWTYlgT9mQ-JHA9_2ZcKJ2FOSxq4_Coktc1AsPQXiscwZqLiL2fbEM5Zs96udQbtaVOIcyD1Kr3zQOH8sC0qNAg0L7-WobHNZPyqKLnT_ZHPxz9olHErRfWcsr6Bdv3-IazS1Nb9phPQFKLV9_g |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LTwIxEJ4gGvGmqAGfPRhuGx9bWIwhZh_dbHUfhF0InMh2LQmXhcga_77TFdCLXppJm0zaSb55tTMFuOl2HoXAQWu_iVSjeoqQkkamSUPqaTvt0mymbnSDsOMN6cu4Pa7AfFMLU_YJ_SybIyKiMsR7Uerr5U8SyynfVq5uxRynFs9u0nNa6-hYhSeoVByrx_qRE9kt20aqFQ56VLnShm7SHdhFD9tQYGAjSxWlLH9bFPcQ9vrILC-OoCLzOtTszcdrddgP1vfdSK6htzqGpyDymT30zQGxzJjHJHKJaybJhPh8xAaEhx63uEo4EWtC4sjhw4BYKgfF4hMgLktsT8NdTLcnnrL-dr_6KVTzRS4bQO5QerN7XYiHWUapkaFhEZ0UlW2q6kdl1oTmn2zO_lm7hpqXBP7U5-HrORwoMX5nLy-gWrx_yEs0u4W4KgX2BTyugPE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MOLECULAR+BASIS+OF+FATTY+LIVER+INHIBITION+BY+SODIUM+BORATES&rft.inventor=CEBECI%2C+Emre&rft.inventor=SAHIN%2C+Fikrettin&rft.inventor=ABDIK%2C+H%C3%BCseyin&rft.date=2024-07-31&rft.externalDBID=A4&rft.externalDocID=EP4251173A4 |